☆ 4.8 Letter

Evidence that CD32a does not mark the HIV-1 latent reservoir

NATURE (2018)

Journal

NATURE

Volume 561, Issue 7723, Pages E20-E28

Publisher

NATURE PUBLISHING GROUP

DOI: 10.1038/s41586-018-0495-2

Keywords

-

Categories

Multidisciplinary Sciences

Funding

NIAID NIH HHS [UM1 AI126617, P01 AI131365, R56 AI122942, T32 AI007387, R01 AI127089, R56 AI091514] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Editorial Material Immunology

Analyzing the unperturbed HIV-1 T cell reservoir

Brianna Lopez, Robert F. Siliciano

Summary: The latent reservoir for HIV-1, which hinders a cure, is challenging to study due to the scarcity of latently infected cells and the absence of distinctive markers. Sun et al. used single cell analysis of T cell surface phenotypes to demonstrate the immune selection of reservoir cells.

TRENDS IN IMMUNOLOGY (2023)

Add to Collection

Article Immunology

HIV-Positive Liver Transplant Does not Alter the Latent Viral Reservoir in Recipients With Antiretroviral Therapy-Suppressed HIV

Sarah E. Benner, Xianming Zhu, Sarah Hussain, Sander Florman, Yolanda Eby, Reinaldo E. Fernandez, Darin Ostrander, Meenakshi Rana, Shane Ottmann, Jonathan Hand, Jennifer C. Price, Marcus R. Pereira, David Wojciechowski, Jacques Simkins, Valentina Stosor, Sapna A. Mehta, Saima Aslam, Maricar Malinis, Ghady Haidar, Allan Massie, Melissa L. Smith, Jonah Odim, Megan Morsheimer, Thomas C. Quinn, Gregory M. Laird, Robert Siliciano, Ashwin Balagopal, Dorry L. Segev, Christine M. Durand, Andrew D. Redd, Aaron A. R. Tobian

Summary: We investigated the impact of receiving a liver transplant on the HIV latent viral reservoir (LVR). LVR did not show any changes in recipients with HIV who received a liver from HIV-positive or HIV-negative donors. The stability of LVR after liver transplantation in people with HIV indicates its importance as a barrier to HIV-1 cure strategies.

JOURNAL OF INFECTIOUS DISEASES (2023)

Add to Collection

Review Immunology

An ordeal that does not heal: understanding barriers to a cure for HIV-1 infection

Mathias Lichterfeld, Ce Gao, Xu G. Yu

Summary: This opinion article proposes a more dynamic interpretation of HIV-1 reservoir cell biology, suggesting that HIV-1 proviruses frequently display residual viral transcriptional activity, making them vulnerable to immune-mediated selection processes. The authors suggest that intensifying and accelerating naturally occurring selection mechanisms might represent a promising strategy for finding a potential cure for HIV-1 infection.

TRENDS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir

Poonam Suryawanshi, Rajani Bagul, Ashwini Shete, Madhuri Thakar

Summary: The study demonstrated that HIV-1 Env could serve as a latency reversal agent (LRA), and only ADCC mediating antibodies were able to kill the reactivated HIV reservoirs. The findings have implications in designing antibody-mediated immunotherapy for eradicating latent HIV reservoir.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

TCR-mimic bispecific antibodies to target the HIV-1 reservoir

Srona Sengupta, Nathan L. Board, Fengting Wu, Milica Moskovljevic, Jacqueline Douglass, Josephine Zhang, Bruce R. Reinhold, Jonathan Duke-Cohan, Jeanna Yu, Madison C. Reed, Yasmine Tabdili, Aitana Azurmendi, Emily J. Fray, Hao Zhang, Emily Han-Chung Hsiue, Katharine Jenike, Ya-Chi Ho, Sandra B. Gabelli, Kenneth W. Kinzler, Bert Vogelstein, Shibin Zhou, Janet D. Siliciano, Scheherazade Sadegh-Nasseri, Ellis L.Reinherz, Robert F. Siliciano

Summary: HIV-1 infection is incurable due to the persistence of the virus in a latent reservoir of resting memory CD4(+) T cells. The lack of effective latency-reversing agents and kill strategies has hindered the success of shock-and-kill approaches. This study develops T cell receptor-mimic antibodies that promote killing of infected cells and lays the foundation for a novel therapeutic killing strategy toward elimination of the HIV-1 reservoir.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Add to Collection

Article Medicine, Research & Experimental

The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy

Natalie F. McMyn, Joseph Varriale, Emily J. Fray, Carolin Zitzmann, Hannah MaCleod, Jun Lai, Anushka Singhal, Milica Moskovljevic, Mauro A. Garcia, Brianna M. Lopez, Vivek Hariharan, Kyle Rhodehouse, Kenneth Lynn, Pablo Tebas, Karam Mounzer, Luis J. Montaner, Erika Benko, Colin Kovacs, Rebecca Hoh, Francesco R. Simonetti, Gregory M. Laird, Steven G. Deeks, Ruy M. Ribeiro, Alan S. Perelson, Robert F. Siliciano, Janet M. Siliciano

Summary: HIV-1 persists in a latent reservoir in resting CD4+ T cells despite antiretroviral therapy. While the reservoir slowly decays over the first 7 years of ART, this decay does not continue with long-term ART. Proliferation of infected cells counteracts the decrease, maintaining the frequency of inducible, replication-competent proviruses at roughly constant levels over the long term. These findings emphasize the need for lifelong ART.

JOURNAL OF CLINICAL INVESTIGATION (2023)

Add to Collection

Article Cell Biology

Combined single-cell transcriptional, translational, and genomic profiling reveals HIV-1 reservoir diversity

Geremy Sannier, Mathieu Dube, Caroline Dufour, Corentin Richard, Nathalie Brassard, Gloria-Gabrielle Delgado, Amelie Pagliuzza, Amy E. Baxter, Julia Niessl, Elsa Brunet-Ratnasingham, Roxanne Charlebois, Bertrand Routy, Jean-Pierre Routy, Remi Fromentin, Nicolas Chomont, Daniel E. Kaufmann

Summary: Understanding the diversity of HIV-1 reservoirs is crucial for a cure, but studying them at the single-cell level in primary samples is challenging. Different viral gene expression and translation patterns are observed in viremic and ART-suppressed individuals, with most reactivated proviruses found to be defective. LRAs induce a wide variety of viral gene transcription and translation patterns, with different effects on various memory cell subsets.

CELL REPORTS (2021)

Add to Collection

Review Immunology

The reservoir of latent HIV

Jing Chen, Tong Zhou, Yuan Zhang, Shumin Luo, Huan Chen, Dexi Chen, Chuanyun Li, Weihua Li

Summary: The persistence of latent HIV reservoir is a major challenge in curing HIV infection. Current antiretroviral therapy is unable to eliminate the latent HIV, hindering the progress of HIV treatment. This review aims to provide a comprehensive understanding of the existence, formation, localization, detection, and removal methods of latent HIV reservoir, in order to assist future research and potential role in achieving HIV treatment.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Impact of misclassified defective proviruses on HIV reservoir measurements

Daniel B. Reeves, Christian Gaebler, Thiago Y. Oliveira, Michael J. Peluso, Joshua T. Schiffer, Lillian B. Cohn, Steven G. Deeks, Michel C. Nussenzweig

Summary: Most proviruses in people living with HIV are defective, but intact proviruses can lead to viral rebound. The two-probe intact proviral DNA assay (IPDA) found 40-fold more intact proviruses compared to the near full length (nfl) Q4PCR. Both assays showed that defective proviruses did not decay over 10 years. However, the average half-lives of intact proviruses were different: 108 months for IPDA and 65 months for Q4PCR. Misclassified defective proviruses and very long-lived intact proviruses could explain this difference.

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Immunology

Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir

Vincent H. Wu, Jayme M. L. Nordin, Son Nguyen, Jaimy Joy, Felicity Mampe, Perla M. del Rio Estrada, Fernanda Torres-Ruiz, Mauricio Gonzalez-Navarro, Yara Andrea Luna-Villalobos, Santiago Avila-Rios, Gustavo Reyes-Teran, Pablo Tebas, Luis J. Montaner, Katharine J. Bar, Laura A. Vella, Michael R. Betts

Summary: In this study, a single-cell strategy was developed to define the HIV-infected memory CD4(+) T cell reservoir in ART-treated people living with HIV (ART-PLWH) using integrated accessible proviral DNA, epigenetic and cell surface protein profiling. The study identified a profound reservoir heterogeneity within and between ART-PLWH, characterized by new and known surface markers within memory CD4(+) T cell subsets. Furthermore, new epigenetic profiles and transcription factor motifs enriched in HIV-infected cells were uncovered, suggesting a potential for reactivation during ART treatment. These findings establish an initial multiomic atlas for targeted reservoir elimination strategies.

NATURE IMMUNOLOGY (2023)

Add to Collection

Article Medicine, Research & Experimental

The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memo CD4+ T cells

Gabriel Duette, Bonnie Hiener, Hannah Morgan, Fernando G. Mazur, Vennila Mathivanan, Bethany A. Horsburgh, Katie Fisher, Orion Tong, Eunok Lee, Haelee Ahn, Ansari Shaik, Remi Fromentin, Rebecca Hoh, Charline Bacchus-Souffan, Najla Nasr, Anthony L. Cunningham, Peter W. Hunt, Nicolas Chomont, Stuart G. Turville, Steven G. Deeks, Anthony D. Kelleher, Timothy E. Schlub, Sarah Palmer

Summary: Through studying CD4(+) T cells of HIV-1 patients, the importance of effector memory T cells in the persistence of HIV-1 has been identified, and Nef has been suggested as a potential therapeutic target.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Add to Collection

Article Immunology

Single-cell epigenetic, transcriptional, and protein profiling of latent and active HIV-1 reservoir revealed that IKZF3 promotes HIV-1 persistence

Yulong Wei, Timothy C. Davenport, Jack A. Collora, Haocong Katherine Ma, Delia Pinto-Santini, Javier Lama, Ricardo Alfaro, Ann Durr, Ya-Chi Ho

Summary: Understanding the proliferation and persistence of HIV-1-infected cells is crucial for eradicating HIV-1. By examining the transcription factor accessibility, transcriptome, surface proteins, HIV-1 DNA, and HIV-1 RNA of single CD4+ memory T cells, we identified specific transcription factor accessibility in latent and transcriptionally active HIV-1-infected cells. Additionally, a proliferation program was found to promote the survival of transcriptionally active HIV-1-infected cells. Different epigenetic programs were also involved in driving the heterogeneous cellular states of HIV-1-infected cells, including activation, cytotoxic effector differentiation, migration, and cell death.

IMMUNITY (2023)

Add to Collection

Article Medicine, Research & Experimental

Layer-by-Layer Particles Deliver Epigenetic Silencing siRNA to HIV-1 Latent Reservoir Cell Types

Ewa Czuba-Wojnilowicz, Vera Klemm, Christina Cortez-Jugo, Stuart Turville, Anupriya Aggarwal, Frank Caruso, Anthony D. Kelleher, Chantelle L. Ahlenstiel

Summary: Nanomaterials have been used for over two decades to deliver siRNA and induce PTGS, but poor intracellular and nuclear delivery hampers silencing efficiency. This study reports on the use of polyarginine-terminated multilayered particles as a versatile system for the delivery of TGS-inducing siRNA to effectively suppress virus transcription in HIV-infected cells. The siRNA is complexed with multilayered particles and taken up by the nuclei of HIV-infected cells, leading to functional virus silencing. This work expands the application of particle-enabled siRNA delivery to the TGS pathway and opens up possibilities for efficient TGS of various diseases and infections, including HIV.

MOLECULAR PHARMACEUTICS (2023)

Add to Collection

Article Microbiology

Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy

Xiaodong Lian, Kyra W. Seiger, Elizabeth M. Parsons, Ce Gao, Weiwei Sun, Gregory T. Gladkov, Isabelle C. Roseto, Kevin B. Einkauf, Matthew R. Osborn, Joshua M. Chevalier, Chenyang Jiang, Jane Blackmer, Mary Carrington, Eric S. Rosenberg, Michael M. Lederman, Deborah K. McMahon, Ronald J. Bosch, Jeffrey M. Jacobson, Rajesh T. Gandhi, Michael J. Peluso, Tae-Wook Chun, Steven G. Deeks, Xu G. Yu, Mathias Lichterfeld

Summary: Long-term antiretroviral therapy (ART) in HIV-1 infected individuals leads to significant changes in the viral reservoir profile, with intact proviruses preferentially integrated in heterochromatin locations. These intact proviruses are more likely to persist and avoid elimination compared to proviruses in permissive chromosomal locations. This altered viral reservoir structure may contribute to deep latency and reduced rebound viremia upon treatment interruptions.

CELL HOST & MICROBE (2023)

Add to Collection

Review Immunology

Are Fc Gamma Receptor Polymorphisms Important in HIV-1 Infection Outcomes and Latent Reservoir Size?

Helena Lamptey, Evelyn Y. Bonney, Bright Adu, George B. Kyei

Summary: Fc gamma receptors play a potential role in HIV-1 infection, treatment, and vaccine trial outcomes. Variations in these outcomes in different individuals may be influenced by multiple factors and the relatively limited data from African populations. Further studies, especially in sub-Saharan Africa, are recommended to confirm the role of Fc gamma receptors in the establishment of latent reservoir and their influence in therapies involving broadly neutralizing antibodies.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Letter Virology

Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy

Daniela Marin-Hernandez, Robert E. Schwartz, Douglas F. Nixon

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Letter Virology

Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Dennis C. Copertino, Rodrigo R. R. Duarte, Timothy R. Powell, Miguel de Mulder Rougvie, Douglas F. Nixon

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Editorial Material Immunology

The Immunologists' Guide to Pandemic Preparedness

Daniela Marin-Hernandez, Nathaniel Hupert, Douglas F. Nixon

TRENDS IN IMMUNOLOGY (2021)

Add to Collection

Letter Biotechnology & Applied Microbiology

Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany

Daniela Marin-Hernandez, Douglas F. Nixon, Nathaniel Hupert

Summary: The BCG vaccine may have protective effects against respiratory infections and potential benefits on COVID-19 outcomes in elderly populations; differential past BCG vaccination policies between East and West Germany provide an opportunity to assess the impact of prior BCG vaccination on COVID-19; study findings support the use of a combined approach involving heterologous vaccines and non-pharmaceutical interventions to mitigate the SARS-CoV-2 pandemic.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection

Dennis C. Copertino, Bruno C. Casado Lima, Rodrigo R. R. Duarte, Timothy R. Powell, Christopher E. Ormsby, Timothy Wilkin, Roy M. Gulick, Miguel de Mulder Rougvie, Douglas F. Nixon

Summary: COVID-19, caused by SARS-CoV-2, has led to a rapidly increasing number of deaths worldwide. Urgent studies are ongoing to identify new antiviral drugs, repurpose existing drugs, or find drugs that can target the overactive immune response. Some research suggests certain antiretroviral drugs may offer protection against the progression of COVID-19.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Add to Collection

Article Multidisciplinary Sciences

Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave

Nathaniel Hupert, Daniela Marin-Hernandez, Bo Gao, Ricardo Aguas, Douglas F. Nixon

Summary: COVID-19 remains a global health threat, and non-COVID-19 vaccines may have nonspecific effects that enhance population immunity and provide some protection against SARS-CoV-2 infection. Mathematical modeling suggests that heterologous vaccine interventions could reduce the spread and mortality of COVID-19, and these findings may be applicable to future viral pandemics.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Add to Collection

Article Medicine, Research & Experimental

Specific human endogenous retroviruses predict metastatic potential in uveal melanoma

Matthew L. Bendall, Jasmine H. Francis, Alexander N. Shoushtari, Douglas F. Nixon

Summary: The study identified four HERV-based subgroups in uveal melanoma, providing clear delineation of risk outcome and supporting other molecular subtypes. Intergenic HERVs with coding potential may represent potential therapeutic targets in tumor classification.

JCI INSIGHT (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Minireview A field guide to endogenous retrovirus regulatory networks

Nicholas Dopkins, Morgan M. O'Mara, Elsa Lawrence, Tongyi Fei, Santiago Sandoval-Motta, Douglas F. Nixon, Matthew L. Bendall

Summary: Germ cells can be infected by exogenous retroviruses, causing the integration of retroviral gene sequences into the genome. These integrated retroviruses, known as ERVs, are commonly found in mammalian genomes and have been co-opted for complex physiological processes. However, unregulated ERV transposition and expression pose a threat to cell fitness and genomic integrity, necessitating the control of ERVs through pre- and post-transcriptional mechanisms.

MOLECULAR CELL (2022)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Two-step recognition of HIV-1 DNA in the cytosol

Nicholas Dopkins, Douglas F. Nixon

Summary: A new study by Yoh et al. revealed that the host factor PQBP1 enhances immune recognition of retroviral DNA by recruiting the cytosolic DNA scavenger cGAS to the HIV-1 capsid, leading to the production of interferons. These findings highlight the significance of innate immune sensing in HIV-1 infection.

TRENDS IN MICROBIOLOGY (2023)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

How human endogenous retroviruses interact with the microbiota in health and disease

Nicholas Dopkins, Morgan M. O'Mara, Bhavya Singh, Jez L. Marston, Matthew L. Bendall, Douglas F. Nixon

Summary: The composition of the microbiota is closely related to human health and disease. Recent evidence suggests that endogenous retroviruses play a role in facilitating communication between the host and microbiota to shape immunity.

TRENDS IN MICROBIOLOGY (2022)

Add to Collection

Review Neurosciences

Transposable elements and Alzheimer's disease pathogenesis

Teresa H. Evering, Jez L. Marston, Li Gan, Douglas F. Nixon

Summary: Alzheimer's disease (AD) is characterized by the accumulation of amyloid beta (A beta) plaques and hyperphosphorylated tau, which trigger the abnormal transcription of transposable elements (TE) by microglia and astrocytes. This forum presents new data linking dysregulated TE expression to AD pathogenesis.

TRENDS IN NEUROSCIENCES (2023)

Add to Collection

Article Microbiology

Endogenous Reverse Transcriptase Inhibition Attenuates TLR5-Mediated Inflammation

Nicholas Dopkins, Bhavya Singh, Stephanie Michael, Morgan M. O'Mara, Jez L. Marston, Tongyi Fei, Matthew L. Bendall, Douglas F. Nixon

Summary: Transposable elements (TEs) are mobile genomic sequences that constitute a significant portion of the human genome. They can be induced by immunostimulatory cues and play a role in host-microbiota interaction. This study demonstrates that toll-like receptor activation alters the expression of retrotransposons and that reverse transcriptase inhibitor delivery can ameliorate the inflammatory response.

MBIO (2023)

Add to Collection

Article Multidisciplinary Sciences

Immune sensing of food allergens promotes avoidance behaviour

Esther B. Florsheim, Nathaniel D. Bachtel, Jaime L. Cullen, Bruna G. C. Lima, Mahdieh Godazgar, Fernando Carvalho, Carolina P. Chatain, Marcelo R. Zimmer, Cuiling Zhang, Gregory Gautier, Pierre Launay, Andrew Wang, Marcelo O. Dietrich, Ruslan Medzhitov

Summary: In addition to protecting the body from pathogens, the immune system can also affect behavior. In this study using mouse models of food allergy, it was found that allergic sensitization leads to antigen-specific avoidance behavior. The avoidance of allergens activates certain brain areas involved in aversive stimuli response. IgE antibodies and mast cells are necessary for allergen avoidance, and cysteinyl leukotrienes and growth and differentiation factor 15 play a role in promoting avoidance. Genetic background also influences avoidance behavior. These findings suggest that antigen-specific behavioral modifications may have evolved to avoid unfavorable environments.

NATURE (2023)

Add to Collection

Review Cell Biology

Activation of human endogenous retroviruses and its physiological consequences

Nicholas Dopkins, Douglas F. Nixon

Summary: This review discusses the importance of human endogenous retroviruses (HERVs), how they have influenced human evolution and physiology, and how they are regulated. It has been found that these viruses play a crucial role in human health, but their study is still underrepresented.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2023)

Add to Collection

Article Virology

HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing

Danielle E. Lyons, Priti Kumar, Nadia R. Roan, Patricia A. Defechereux, Cedric Feschotte, Ulrike C. Lange, Niren Murthy, Pauline Sameshima, Eric Verdin, Julie A. Ake, Matthew S. Parsons, Avindra Nath, Sara Gianella, Davey M. Smith, Esper G. Kallas, Thomas J. Villa, Richard Strange, Betty Mwesigwa, Robert L. Furler O'Brien, Douglas F. Nixon, Lishomwa C. Ndhlovu, Susana T. Valente, Melanie Ott

Summary: This article proposes a novel approach to cure HIV-1 infection by silencing viral expression for long-term control without antiretroviral therapy. The approach is based on research into HIV-1 latency mechanisms, lessons from latency reversing agents, and knowledge of retroviral evolution. Insights from elite controllers and advanced genome engineering technologies offer potential routes to a rapid cure for HIV-1.

VIRUSES-BASEL (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.